Answers are grounded in this paper and cite their sources.
Post-keratoplasty endothelial cell density (ECD) is modeled with phenomenological decay curves that do not account for underlying cellular mechanisms or identify potential therapeutic targets. We built a two-phase (early, then long-term loss) agent-based mechanistic digital twin, calibrated to the Cornea Preservation Time Study (CPTS; 995 subjects, post-DSAEK) and tested in the Cornea Donor Study (CDS; 469 subjects, post-PKP). ECD identified a 21% early postoperative loss and a net ECD-loss rate of 0.0064 month⁻¹, but not proliferation, migration or guttae formation. The simulator matched held-out CPTS 48-month means (residuals − 26 to + 21 cells/mm²; constant-rate comparator − 325 to − 295); in CDS, per-eye calibration outperformed only carry-forward and the CPTS-calibrated cohort posterior. Decay-twin 80% intervals covered 79.6% (CPTS) and 82.3% (CDS); the image feeder’s error averaged 150 cells/mm². A bounded in-silico ROCK-inhibitor counterfactual gave mean 36-month preservation from 94 (95% interval − 4 to 280) to 266 (0 to 821) cells/mm² across drug targets.
No takes yet. Share an insight, caveat, or question.
Chuter et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: